Lipids and the Emerging RNA Medicines

ADVERTISEMENT RETURN TO ISSUEPREVHighlightNEXTLipids and the Emerging RNA MedicinesYuling XiaoYuling XiaoCenter for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United StatesMore by Yuling Xiao and Jinjun Shi*Jinjun ShiCenter for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United StatesMore by Jinjun ShiCite this: Chem. Rev. 2021, 121, 20, 12109–12111Publication Date (Web):October 27, 2021Publication History Received4 September 2021Published online27 October 2021Published inissue 27 October 2021https://pubs.acs.org/doi/10.1021/acs.chemrev.1c00778https://doi.org/10.1021/acs.chemrev.1c00778in-briefACS PublicationsCopyright © Published 2021 by American Chemical SocietyRequest reuse permissionsArticle Views2309Altmetric-Citations6LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Gene delivery,Genetics,Lipids,Pharmaceuticals,Vaccination Get e-Alerts